You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Baxter
Colorcon
Boehringer Ingelheim
Express Scripts

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

KLONOPIN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Klonopin patents expire, and when can generic versions of Klonopin launch?

Klonopin is a drug marketed by Roche and is included in two NDAs.

The generic ingredient in KLONOPIN is clonazepam. There are ten drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the clonazepam profile page.

US ANDA Litigation and Generic Entry Outlook for Klonopin

A generic version of KLONOPIN was approved as clonazepam by TEVA on September 10th, 1996.

  Start Trial

Drug patent expirations by year for KLONOPIN
Drug Prices for KLONOPIN

See drug prices for KLONOPIN

Drug Sales Revenue Trends for KLONOPIN

See drug sales revenues for KLONOPIN

Recent Clinical Trials for KLONOPIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, Los AngelesPhase 4
Palo Alto Veterans Institute for ResearchPhase 4
Stanford UniversityPhase 4

See all KLONOPIN clinical trials

Pharmacology for KLONOPIN
Drug ClassBenzodiazepine

US Patents and Regulatory Information for KLONOPIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche KLONOPIN clonazepam TABLET;ORAL 017533-005 Apr 9, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-002 Dec 23, 1997 DISCN Yes No   Start Trial   Start Trial   Start Trial
Roche KLONOPIN clonazepam TABLET;ORAL 017533-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-003 Dec 23, 1997 DISCN Yes No   Start Trial   Start Trial   Start Trial
Roche KLONOPIN clonazepam TABLET;ORAL 017533-006 Apr 9, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Roche KLONOPIN clonazepam TABLET;ORAL 017533-001 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial   Start Trial
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-001 Dec 23, 1997 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for KLONOPIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche KLONOPIN clonazepam TABLET;ORAL 017533-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Roche KLONOPIN clonazepam TABLET;ORAL 017533-003 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Roche KLONOPIN clonazepam TABLET;ORAL 017533-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
AstraZeneca
Harvard Business School
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.